v3.26.1
STOCK OPTIONS
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
STOCK OPTIONS

7. STOCK OPTIONS

 

Stock options issued during the three months ended March 31, 2026 and the three months ended March 31, 2025

 

No stock options were granted to directors, advisors, or employees during the three months ended March 31, 2026 or the three months ended March 31, 2025.

 

For the three months ended March 31, 2025, the Company recorded $4,490 in stock-based compensation expense related to vested stock options. At March 31, 2026, there was no unamortized cost of stock-based awards.

 

A summary of the Company’s stock option activity during the three months ended March 31, 2026 is as follows:

 

   Shares  

Weighted

Average

Exercise Price

 
Balance Outstanding at December 31, 2025   13,193,376   $0.40 
Granted   -    - 
Exchanged   -    - 
Exercised   -    - 
Expired   (7,500)   1.50 
Forfeited   -    - 
Balance Outstanding at March 31, 2026   13,185,876   $0.40 
Balance Exercisable at March 31, 2026   13,185,876   $0.40 

 

At March 31, 2026, the 13,185,876 outstanding stock options had $630 of intrinsic value.

 

 

A summary of the Company’s stock options outstanding and exercisable as of March 31, 2026 is as follows:

  

   Number of Options  

Weighted

Average

Exercise

Price

  

Weighted

Average

Grant- Date

Stock Price

 
Options Outstanding and Exercisable, March 31, 2026   100,000   $0.1337   $0.1337 
    750,000   $0.148   $0.148 
    950,000   $0.15   $0.15 
    3,050,000   $0.18   $0.18 
    1,550,000   $0.212   $0.212 
    1,150,000   $0.277   $0.277 
    750,000   $0.30   $0.30 
    2,000,000   $0.35   $0.35 
    250,000   $0.38   $0.38 
    1,664,542   $0.50   $0.50 
    128,000   $0.96   $0.96 
    343,334   $ 1.50 - 1.95   $1.50 - 1.95 
    500,000   $2.00 - 2.79   $2.00 - 2.79 
    13,185,876